Versant Capital Management »

Avita Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6k 441 3.70
2025-03-31 $4.7k 576 8.14
2024-12-31 $7.2k 559 12.80

More positions owned by Versant Capital Management

Microsoft Stock (MSFT)
Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ishares S&p Global Energy Etf (IXC)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Avago Technologies Stock (AVGO)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Vanguard Total Stk Mkt Etf (VTI)
State Street Spdr S&p Global Natural Resources Etf Etf (GNR)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)

View all positions for Versant Capital Management

Top funds holding Avita Therapeutics

OrbiMed Advisors
Vanguard Group
Vanguard Capital Management
BlackRock
Geode Capital Management
State Street Corporation
Vanguard Fiduciary Trust
Northern Trust
Morgan Stanley
Bridgeway Capital Management
Divisadero Street Capital Management
Goldman Sachs Group
AQR Capital Management
Vanguard Portfolio Management
UBS Group

View all funds holding Avita Therapeutics